These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22185755)

  • 1. Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events.
    Lishmanov A; Dorairajan S; Pak Y; Chaudhary K; Chockalingam A
    Am J Ther; 2013; 20(5):480-6. PubMed ID: 22185755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
    Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
    Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.
    Kumar J; McDermott K; Abraham AG; Friedman LA; Johnson VL; Kaskel FJ; Furth SL; Warady BA; Portale AA; Melamed ML
    Pediatr Nephrol; 2016 Jan; 31(1):121-9. PubMed ID: 26307635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large Doses of Vitamin D Fail to Increase 25-Hydroxyvitamin D Levels or to Alter Cardiovascular Risk Factors in Obese Adolescents: A Pilot Study.
    Shah S; Wilson DM; Bachrach LK
    J Adolesc Health; 2015 Jul; 57(1):19-23. PubMed ID: 25873553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008.
    Oh YJ; Kim M; Lee H; Lee JP; Kim H; Kim S; Oh KH; Joo KW; Lim CS; Kim S; Kim YS; Kim DK
    Nephrol Dial Transplant; 2012 Jun; 27(6):2396-403. PubMed ID: 22262736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients.
    Agarwal G; Vasquez K; Penagaluru N; Gelfond J; Qunibi WY
    Hemodial Int; 2015 Oct; 19(4):499-508. PubMed ID: 25790374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
    Boudville NC; Hodsman AB
    Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Vitamin D deficiency in predialysis patients with stage 3-5 chronic kidney diseases in Southern China.
    Feng M; Lv J; Huang FT; Liang PF; Fu S; Zeng YC; Tang Y; Xu AP
    Niger J Clin Pract; 2017 Oct; 20(10):1309-1315. PubMed ID: 29192637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Bishop CW; Strugnell SA; Csomor P; Kaiser E; Ashfaq A
    Am J Nephrol; 2022; 53(6):446-454. PubMed ID: 35551374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial stiffness and 25-hydroxyvitamin D levels in chronic kidney disease patients.
    Akdam H; Alp A
    Rev Assoc Med Bras (1992); 2017 Oct; 63(10):910-916. PubMed ID: 29267494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study.
    Welsh P; Doolin O; McConnachie A; Boulton E; McNeil G; Macdonald H; Hardcastle A; Hart C; Upton M; Watt G; Sattar N
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4578-87. PubMed ID: 23071162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent associations of vitamin D metabolites with anemia in patients referred to coronary angiography: the LURIC study.
    Ernst JB; Zittermann A; Pilz S; Kleber ME; Scharnagl H; Brandenburg VM; König W; Grammer TB; März W
    Eur J Nutr; 2017 Apr; 56(3):1017-1024. PubMed ID: 26746220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study.
    Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Zoller O; Theler JM; Paccaud F; Burnier M; Bochud M;
    J Ren Nutr; 2014 Sep; 24(5):303-12. PubMed ID: 25030223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
    Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cavalier E; Chanson P
    Endocrine; 2016 Aug; 53(2):543-50. PubMed ID: 27106800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease.
    Lishmanov A; Dorairajan S; Pak Y; Chaudhary K; Chockalingam A
    Int Urol Nephrol; 2012 Apr; 44(2):541-7. PubMed ID: 21327525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD.
    Damasiewicz MJ; Magliano DJ; Daly RM; Gagnon C; Lu ZX; Sikaris KA; Ebeling PR; Chadban SJ; Atkins RC; Kerr PG; Shaw JE; Polkinghorne KR
    Am J Kidney Dis; 2013 Jul; 62(1):58-66. PubMed ID: 23623574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.